Archives
Parabolic Drugs Limited is a vertically integrated, research based, Pharmaceutical manufacturer and exporter, specializing in development and manufacturing of Active Pharmaceutical Ingredients (API) and API intermediates. The Company has dedicated facilities for Custom Research and API manufacturing at its 4 locations, 2 in Haryana (India) and 2 in Punjab (India) and exporting to over 51…
→ Read more
Analyst Corner- Research Reports on PDL The Following is the list of coverage for Parabolic Drugs Limited from different analysts Research House Analyst Name Download Link India Infoline(IIFL) Amar Ambani/Akash Jain IIFL Research Avendus- India Equity Research Monika Joshi Avendus Research Disclaimer Parabolic Drugs Limited has no relations with any of these institutions and makes…
→ Read more
Investor Relations and Corporate Communication/Compliance Officer : Mr. Sushil Kapoor (Chief Financial Officer) Email: sushil.kapoor@parabolicdrugs.com
→ Read more
Please contact : Mr. R.P. Singh (Vice President- Materials) Email : rpsingh@parabolicdrugs.com
→ Read more
For more queries related to our CRAMS business: Shishant Gupta D.G.M.(Business Development ) +91-1733-256380 (Ext.115) ,+91-93177-49872 (M) Email: crams@parabolicdrugs.com shishantg@parabolicdrugs.com
→ Read more
For more queries related to our business Marketing Team-API Email: businessteam@parabolicdrugs.com Phone : +91 93177 49894, +91-172 3914637
→ Read more
WHO-GMP ACCREDITATION FOR PARABOLIC CEPHALOSPORIN FACILITY The Company’s dedicated Cephalosporin API manufacturing Site at Derabassi has been accredited with the WHO-GMP certificate by the Central Drugs Standards Control Organization, DGHS, Ministry of Health & Family Welfare. The Derabassi Campus, housing six manufacturing Plants, two Solvant Recovery Plants, a dedicated Quality Control and Quality Assurance unit,…
→ Read more
PARABOLIC ACCREDITED WITH ISO 14001 CERTIFICATION The Company’s Derabassi manufacturing Site has been accredited with the ISO 14001:2004 certificate for meeting the Environmental Management System Standards. This 27 acre facility, a dedicated Cephalosporin API & intermediate manufacturing site, was audited by DNV (Det Norske Veritas) certification agency from Netherlands and found to be compliant…
→ Read more
BTS India Private Equity Fund Limited, a Mauritius based Company registered with the Securities and Exchange Board of India (SEBI) as Foreign Venture Capital Investor has invested around USD 7 million in the Company by way of private placement of shares.
→ Read more
PDL received Certificate of suitability from the office of European Directorate for the Quality of Medicines & HealthCare, France Monday July16,2007 The Director of European Directorate for the Quality of Medicines & HealthCare has issued certificate of suitability no.RO-CEP 2005-064-Rev 00 to the Company for its product-Flucloxacillin Sodium.
→ Read more